Upgrade to SI Premium - Free Trial

Morgan Stanley Starts MyoKardia (MYOK) at Overweight

September 10, 2018 7:32 AM
Morgan Stanley analyst Jeffrey Hung initiates coverage on MyoKardia (NASDAQ: MYOK) with a Overweight rating and a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage